Filing Flows › InspireMD (NSPR) › Who owns the stock
Who owns InspireMD (NSPR) stock
34 funds reported InspireMD (NSPR) shares in their latest 13F filings, worth $17.0M in all. The largest holder is Nantahala Capital Management, LLC ($4.7M). Last quarter 12 funds added to their stakes and 14 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,752,968 | $4.7M | increase | 2026-06-30 |
| Rosalind Advisors | 3,905,743 | $2.7M | unchanged | 2026-06-30 |
| abrdn | 3,698,364 | $2.6M | increase | 2026-06-30 |
| Orbimed Advisors LLC | 3,133,405 | $2.2M | unchanged | 2026-06-30 |
| Parkman Healthcare Partners LLC | 2,416,518 | $1.7M | unchanged | 2026-06-30 |
| Marshall Wace, LLP | 1,860,405 | $1.3M | unchanged | 2026-06-30 |
| Soleus Capital Management, L.P. | 1,045,708 | $732K | unchanged | 2026-06-30 |
| Ingalls & Snyder LLC | 368,800 | $258K | decrease | 2026-06-30 |
| Affiance Financial, LLC | 250,370 | $167K | unchanged | 2026-09-30 |
| Velan Capital Investment Management LP | 148,138 | $104K | decrease | 2026-06-30 |
| BlackRock | 122,993 | $86K | increase | 2026-06-30 |
| Renaissance Technologies LLC | 112,832 | $79K | increase | 2026-06-30 |
| Schonfeld Strategic Advisors LLC | 99,275 | $70K | new | 2026-06-30 |
| XTX Topco | 49,029 | $34K | increase | 2026-06-30 |
| Centiva Capital, LP | 44,123 | $31K | increase | 2026-06-30 |
InspireMD's latest quarter
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most NSPR stock?
By the latest 13F filings: Nantahala Capital Management, LLC ($4.7M); Rosalind Advisors ($2.7M); abrdn ($2.6M); Orbimed Advisors LLC ($2.2M); Parkman Healthcare Partners LLC ($1.7M).
What is the short interest in NSPR?
80,900 shares were sold short at the 2026-10-15 settlement, 260.1% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.